A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects
Clinical trial NCT02873156 · COMPLETED
Trial details
- NCT number
- NCT02873156
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-10
- Primary completion
- 2017-11-29
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.